Search

Your search keyword '"Openshaw, Peter J M"' showing total 451 results

Search Constraints

Start Over You searched for: Author "Openshaw, Peter J M" Remove constraint Author: "Openshaw, Peter J M"
451 results on '"Openshaw, Peter J M"'

Search Results

1. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

2. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

3. Accelerated immune ageing is associated with COVID-19 disease severity

4. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study

5. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies

7. Obesity dysregulates the pulmonary antiviral immune response

8. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

9. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

10. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

11. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

12. Whole-genome sequencing reveals host factors underlying critical COVID-19

13. Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

14. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

15. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study

16. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19.

17. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

18. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom : prospective multicentre observational cohort study

19. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

20. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

21. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study

22. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

24. Tracheostomy in the COVID-19 era: global and multidisciplinary guidance

25. T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

27. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

29. A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants.

30. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults.

31. Natural killer cells and innate lymphoid cells but not NKT cells are mature in their cytokine production at birth.

33. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection

34. Whole-genome sequencing reveals host factors underlying critical COVID-19

36. Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants.

37. Association between disease severity and co-detection of respiratory pathogens in infants with RSV infection

38. Respiratory viruses: New frontiers—a Keystone Symposia report

39. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study

40. International Pediatric COVID-19 Severity Over the Course of the Pandemic

41. Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

42. Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

43. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages

45. 1H NMR Signals from Urine Excreted Protein Are a Source of Bias in Probabilistic Quotient Normalization

46. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses

47. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

48. Implementation of corticosteroids in treating COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK:prospective observational cohort study

49. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19.

50. Fewer COVID‐19 Neurological Complications with Dexamethasone and Remdesivir.

Catalog

Books, media, physical & digital resources